Prospera Financial Services Inc reduced its position in shares of Clorox Co. (NYSE:CLX) by 3.0% during the second quarter, Holdings Channel reports. The firm owned 1,660 shares of the company’s stock after selling 52 shares during the period. Prospera Financial Services Inc’s holdings in Clorox were worth $230,000 at the end of the most recent reporting period.
Several other institutional investors have also recently added to or reduced their stakes in the stock. Checchi Capital Advisers LLC raised its position in Clorox by 1.0% in the second quarter. Checchi Capital Advisers LLC now owns 820 shares of the company’s stock worth $113,000 after buying an additional 8 shares during the period. Invictus RG purchased a new position in Clorox during the first quarter worth approximately $110,000. Paragon Capital Management Ltd purchased a new position in Clorox during the second quarter worth approximately $232,000. Sii Investments Inc. WI raised its position in Clorox by 29.8% in the first quarter. Sii Investments Inc. WI now owns 2,115 shares of the company’s stock worth $267,000 after buying an additional 485 shares during the period. Finally, Sand Hill Global Advisors LLC raised its position in Clorox by 12.7% in the first quarter. Sand Hill Global Advisors LLC now owns 2,142 shares of the company’s stock worth $270,000 after buying an additional 241 shares during the period. Institutional investors own 70.26% of the company’s stock.
Clorox Co. (NYSE:CLX) traded down 0.66% on Monday, hitting $125.69. 773,925 shares of the company’s stock traded hands. The stock has a 50 day moving average price of $128.79 and a 200-day moving average price of $130.13. Clorox Co. has a 12 month low of $113.37 and a 12 month high of $140.47. The stock has a market cap of $16.27 billion, a P/E ratio of 25.55 and a beta of 0.33.
Clorox (NYSE:CLX) last released its quarterly earnings results on Wednesday, August 3rd. The company reported $1.26 EPS for the quarter, missing the Thomson Reuters’ consensus estimate of $1.28 by $0.02. Clorox had a net margin of 11.25% and a return on equity of 296.91%. The business had revenue of $1.60 billion for the quarter, compared to analysts’ expectations of $1.58 billion. During the same period in the previous year, the company earned $1.44 EPS. Clorox’s revenue for the quarter was up 2.8% compared to the same quarter last year. Equities analysts predict that Clorox Co. will post $5.49 earnings per share for the current fiscal year.
The company also recently announced a quarterly dividend, which will be paid on Monday, November 14th. Investors of record on Wednesday, October 26th will be issued a $0.80 dividend. This represents a $3.20 annualized dividend and a yield of 2.55%. The ex-dividend date of this dividend is Monday, October 24th. Clorox’s dividend payout ratio is 64.91%.
A number of equities analysts have recently commented on the stock. B. Riley restated a “neutral” rating and issued a $109.00 price objective on shares of Clorox in a research report on Thursday, August 4th. Atlantic Securities assumed coverage on shares of Clorox in a research report on Tuesday, June 14th. They issued a “neutral” rating and a $138.00 price objective for the company. Zacks Investment Research upgraded shares of Clorox from a “sell” rating to a “hold” rating in a research report on Tuesday, July 12th. Jefferies Group reaffirmed a “hold” rating on shares of Clorox in a research note on Wednesday, August 3rd. Finally, Goldman Sachs Group Inc. reaffirmed a “neutral” rating and issued a $131.00 target price (up from $125.00) on shares of Clorox in a research note on Friday, July 15th. Two research analysts have rated the stock with a sell rating, seven have issued a hold rating and two have given a buy rating to the company’s stock. The company currently has an average rating of “Hold” and a consensus target price of $128.90.
In related news, COO Nikolaos A. Vlahos sold 925 shares of the stock in a transaction that occurred on Wednesday, August 10th. The shares were sold at an average price of $133.07, for a total value of $123,089.75. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, EVP Laura Stein sold 38,882 shares of the stock in a transaction that occurred on Friday, September 2nd. The stock was sold at an average price of $131.69, for a total transaction of $5,120,370.58. Following the completion of the sale, the executive vice president now directly owns 48,501 shares of the company’s stock, valued at $6,387,096.69. The disclosure for this sale can be found here. 2.09% of the stock is currently owned by corporate insiders.
Clorox Company Profile
The Clorox Company is a manufacturer and marketer of consumer and professional products. The Company sells its products primarily through mass retail outlets, e-commerce channels, wholesale distributors and medical supply distributors. The Company operates through four segments: Cleaning, Household, Lifestyle and International.
Want to see what other hedge funds are holding CLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Clorox Co. (NYSE:CLX).
Receive News & Ratings for Clorox Co. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox Co. and related companies with MarketBeat.com's FREE daily email newsletter.